Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | KCNJ1 | P48048 | 2/20 | 0.56 |
| ▸ | IDO1 | P14902 | 3/20 | 0.53 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.53 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7504059 | 0.98 | LOXL2 (0.62) | LOXL2TSHRKCNJ1IDO1KCNH2 | |
| SCHEMBL1334549 | 0.94 | LOXL2 (0.62) | LOXL2TSHRKCNJ1IDO1KCNH2 | |
| Bromide SCHEMBL10353479 | 0.92 | LOXL2 (0.60) | LOXL2TSHRKCNJ1IDO1KCNH2 | |
| SCHEMBL15807619 | 0.92 | LOXL2 (0.60) | LOXL2TSHRKCNJ1IDO1KCNH2 | |
| Hydrochloric Acid SCHEMBL17260639 | 0.92 | LOXL2 (0.60) | LOXL2TSHRKCNJ1IDO1KCNH2 | |
| SCHEMBL335044 | 0.88 | LOXL2 (0.69) | LOXL2TSHRKCNJ1IDO1KCNH2 | |
| SCHEMBL18913824 | 0.87 | TSHR (0.69) | LOXL2TSHRKCNJ1IDO1KCNH2 | |
| SCHEMBL30758863 | 0.87 | TSHR (0.69) | LOXL2TSHRKCNJ1IDO1KCNH2 | |
| SCHEMBL22408761 | 0.87 | KCNJ1 (0.55) | LOXL2TSHRKCNJ1IDO1KCNH2 | |
| SCHEMBL16572121 | 0.86 | KCNH2 (0.57) | LOXL2TSHRKCNJ1IDO1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121431735-B | Characterization method of molecular weight and molecular weight distribution of crystalline polyaryletherketone | 吉林大学 | 2026-05-19 | — | — | CN | claimed |
| EP-3041365-B1 | USE OF A FEED COMPOSITION FOR REDUCING METHANE EMISSION IN RU-MINANTS, AND/OR TO IMPROVE RUMINANT PERFORMANCE | DSM IP ASSETS BV (NL) | 2018-04-04 | — | — | EP | claimed |
| EP-3041365-A1 | USE OF A FEED COMPOSITION FOR REDUCING METHANE EMISSION IN RU-MINANTS, AND/OR TO IMPROVE RUMINANT PERFORMANCE | DSM IP Assets B.V. (NL) | 2016-07-13 | — | — | EP | claimed |
| US-20160183564-A1 | USE OF A FEED COMPOSITION FOR REDUCING METHANE EMISSION IN RUMINANTS, AND OR TO IMPROVE RUMINANT PERFORMANCE | DSM IP ASSETS B.V. (NL) | 2016-06-30 | — | — | US | claimed |
| EP-2830434-B1 | USE OF PARA NITRO AMINO DERIVATIVES IN FEED FOR REDUCING ME-THANE EMISSION IN RUMINANTS | DSM IP ASSETS BV (NL) | 2016-03-16 | — | — | EP | claimed |
| US-20150064305-A1 | USE OF PARA NITRO AMINO DERIVATIVES IN FEED FOR REDUCING METH-ANE EMISSION IN RUMINANTS | DSM IP ASSETS B.V. (NL) | 2015-03-05 | — | — | US | claimed |
| WO-2015018726-A1 | USE OF A FEED COMPOSITION FOR REDUCING METHANE EMISSION IN RU-MINANTS, AND/OR TO IMPROVE RUMINANT PERFORMANCE | DSM IP ASSETS B.V. (NL) | 2015-02-12 | — | — | WO | claimed |
| EP-2830434-A1 | USE OF PARA NITRO AMINO DERIVATIVES IN FEED FOR REDUCING ME-THANE EMISSION IN RUMINANTS | DSM IP Assets B.V. (NL) | 2015-02-04 | — | — | EP | claimed |
| WO-2013144786-A1 | USE OF PARA NITRO AMINO DERIVATIVES IN FEED FOR REDUCING ME-THANE EMISSION IN RUMINANTS | DSM IP ASSETS B.V. (NL) | 2013-10-03 | — | — | WO | claimed |
| EP-2644038-A1 | Use of para nitro amino derivatives in feed for reducing meth-ane emission in ruminants | DSM IP Assets B.V. (NL) | 2013-10-02 | — | — | EP | claimed |
| CN-121431735-B | Characterization method of molecular weight and molecular weight distribution of crystalline polyaryletherketone | 吉林大学 | 2026-05-19 | — | — | CN | disclosed |
| CN-118290816-A | Recovery method of fiber-reinforced polyaryletherketone resin matrix composite material | 吉林大学 | 2024-07-05 | — | — | CN | disclosed |
| US-20230027075-A1 | SULFONAMIDE COMPOUNDS TARGETING CD73 AND ADENOSINE RECEPTORS | AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) | 2023-01-26 | — | — | US | disclosed |
| EP-4065590-A1 | SULFONAMIDE COMPOUNDS TARGETING CD73 AND ADENOSINE RECEPTORS | Aurigene Discovery Technologies Limited (IN) | 2022-10-05 | — | — | EP | disclosed |
| CN-114728998-A | Sulfonamide compounds targeting CD73 and adenosine receptors | 奥瑞基尼探索技术有限公司 | 2022-07-08 | — | — | CN | disclosed |
| WO-1992002214-A1 | AICA RIBOSIDE ANALOGS | GENSIA PHARMACEUTICALS, INC. (US) | 1992-02-20 | — | — | WO | disclosed |
| WO-1992002213-A1 | METHODS OF PREVENTING OR DECREASING TISSUE DAMAGE BY NOVEL ANTIOXIDANTS AND FREE RADICAL SCAVENGERS | GENSIA PHARMACEUTICALS, INC. (US) | 1992-02-20 | — | — | WO | disclosed |
| US-5008267-A | Pyrimidinedione compounds, method of producing the same and antiarrythmic agents containing the same | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1991-04-16 | — | — | US | disclosed |
| EP-0404146-A2 | Enantiomeric enrichment and stereoselective synthesis of chiral amines | CELGENE CORPORATION (US) | 1990-12-27 | — | — | EP | disclosed |
| EP-0369627-A2 | Pyrimidinedione derivative compounds, method of producing the same and antiarrythmic agents containing the same | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1990-05-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230027075-A1 | SULFONAMIDE COMPOUNDS TARGETING CD73 AND ADENOSINE RECEPTORS | ADORA2A, ADORA2B, ENTPD5 | LOXL2 3751/4885TSHR 134/4885KCNJ1 1515/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.